SCHEMBL30433767

SCHEMBL30433767

Cc1nnc2ccsc2c1O

nearest known ligand 0.33

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 10/20 0.33
ADORA1 P30542 6/20 0.33
AXL P30530 1/20 0.33
MKNK1 Q9BUB5 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
ADORA2B P29275 3/20 0.33
RAB9A P51151 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
NPC1 O15118 1/20 0.32
PDPK1 O15530 1/20 0.32
PARP1 P09874 1/20 0.32
HTT P42858 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
GPR35 Q9HC97 1/20 0.31
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30433880 0.79 ADORA2A (0.37) ADORA2AADORA1AXLMKNK1MKNK2
SCHEMBL25176771 0.71 AXL (0.35) ADORA2AADORA1AXLMKNK1MKNK2
SCHEMBL11316439 0.66 DYRK1A (0.34) RAB9ASMN1; SMN2NPC1HTTMEN1
SCHEMBL20674132 0.65 AXL (0.34) AXLMKNK1MKNK2PDPK1PARP1
SCHEMBL13182502 0.65 AXL (0.34) ADORA2AADORA1AXLMKNK1MKNK2
SCHEMBL6290090 0.65 MEN1 (0.47) ADORA2AADORA1ADORA2BSMN1; SMN2NPC1
SCHEMBL25172345 0.64 PDPK1 (0.37) NPC1PDPK1PARP1
SCHEMBL5334843 0.64 ADORA2A (0.50) ADORA2AADORA1AXLMKNK1MKNK2
SCHEMBL10740688 0.63 ALDH1A1 (0.38) ADORA2AADORA1AXLMKNK1MKNK2
SCHEMBL13778445 0.63 AXL (0.48) ADORA2AADORA1AXLMKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4426702-A1 CONDENSED-PYRAZINE AMINE DERIVATIVES FOR TREATING SCA3 Skyhawk Therapeutics, Inc. (US) 2024-09-11 EP disclosed
WO-2023081858-A1 CONDENSED-PYRAZINE AMINE DERIVATIVES FOR TREATING SCA3 SKYHAWK THERAPEUTICS, INC. (US) 2023-05-11 WO disclosed